The FDA has recently announced that they approve of a pill that would increase sexual desire in women.
“It’s not about the particular love making techniques, it’s about what’s going on in the brain, and a chemical thing,” said licensed Marriage and Family Therapist Lori Holloway.
Many people are calling this pill the female version of Viagra, but that’s not an accurate description.
“Viagra is about sexual performance. It increases the blood flow to the sexual organs. This is a different thing. This works on neuro-transmitters in the brain, and it impacts desire,” Holloway said.
Holloway said that sometimes she deals with couples having sexual issues, and thinks that Addyi, known generically as flibanserin, could help their situations.
She said that this could help to make a couple’s sexual desire equal.
Before jumping to conclusions about needing the pill, Holloway said that it’s always safe to see a doctor.
The drug’s label will bear a boxed warning alerting doctors and patients that combining the pill with alcohol can cause dangerously low blood pressure and fainting. That same risk can occur when taking the drug with other commonly prescribed medications, including antifungals used to treat yeast infections.
“This is not a drug you take an hour before you have sex. You have to take it for weeks and months in order to see any benefit at all,” said Leonore Tiefer, a psychologist and sex therapist who organized a petition last month calling on the FDA to reject the drug.
Doctors will only be able to prescribe this drug after completing an online certification test demonstrating that they understand its side effects. Pharmacies will also have to be certified.
Women with insurance can expect to pay between $30 and $75 per month for Addyi, depending on the terms of their coverage.
The FDA specifically approved the drug for premenopausal women with hypoactive sexual desire disorder, described as a lack of sexual appetite that causes emotional distress.
Addyi is expected to be released in mid-October.